Company Filing History:
2 out of 1,194 
2 out of 1,591 
1 out of 2,355 
Years Active: 1999-2015
Title: David E Reichert: Innovator in Radiolabeled Complexes and MRI Contrast Agents
Introduction
David E Reichert is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of radiochemistry and medical imaging. With a total of 3 patents, his work focuses on innovative methods and compositions that enhance the preparation of radiolabeled complexes and MRI contrast agents.
Latest Patents
One of Reichert's latest patents is titled "Microreactor and method for preparing a radiolabeled complex or a biomolecule conjugate." This invention features a microreactor designed for the efficient preparation of radiolabeled complexes. The microreactor includes a microchannel for fluid flow, which contains a mixing portion with passive mixing elements and a reservoir for incubating mixed fluids. The method involves flowing a radiometal solution through the microchannel, where it is mixed with a ligand solution to initiate a chelation reaction, ultimately forming a radiolabeled complex.
Another significant patent is for "Tripodal aromatic heterocycle carboxamide MRI contrast agents." This composition of matter has specific applications as MRI contrasting agents, enhancing the imaging capabilities in medical diagnostics.
Career Highlights
Throughout his career, David E Reichert has worked with prominent organizations, including Hoechst Celanese Corporation and Washington University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of radiochemistry and medical imaging.
Collaborations
Reichert has collaborated with esteemed colleagues such as Wei-Jen Peng and Paul J A Kenis. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
David E Reichert's contributions to the fields of radiochemistry and medical imaging are noteworthy. His innovative patents and collaborations reflect his commitment to advancing technology in these critical areas. His work continues to impact the development of effective medical imaging solutions.